Michael Corr

Renal SpR | ICAT Fellow | Kidney Transplantation

[Michael Corr @CorrMP]

@nigelhart Thanks! A success that includes the whole health service

Not possible without our primary care colleagues who diagnose & manage most patients with CKD. Early detection and appropriate referral to us makes it possible

Shows what is at risk with such pressures on the system

[Michael Corr @CorrMP]

Our paper in Transplantation shows that over 20 years, deprivation strongly shapes kidney transplant access and outcomes in England but not in Northern Ireland, within the same NHS framework. The contrast points to service organisation, not policy alone.
https://t.co/LVTM04zxKT

[Davog McCaffrey @DavogMcCaffrey]

🚨New publication in @BMJ_Open!

Delighted to share our recently published article, entitled “Transformative learning through communal documentary viewing: a mixed methods study on kidney transplantation and organ donation in medical education”.

🔗 https://t.co/CHV4n9qZ7P

[Michael Corr @CorrMP]

Young kidney recipients aren’t “small adults”. Large naïve T/B pools, active GCs and responsive NK cells amplify rejection risk. We argue for age- and immune-phenotype-informed immunosuppression & research.

#Transplantation #NephTwitter #Immunology
https://t.co/oDCot6wj4r

[Transplantation @TransplantJrnl]

The bioinformatic tool HLA-EP-RESOLVER accurately predicts antibody reactivity to rare HLA alleles using eplet analysis. Validated in sensitized patients, it helps identify acceptable/unacceptable antigens in the era of high-resolution donor typing. #HLA https://t.co/EbGVoeT4Tp

[Transplantation @TransplantJrnl]

Not all antibody tests agree: this study shows big differences between commercial assays for non-HLA antibodies in kidney transplant rejection. Standardization is urgently needed to clarify their role in AMR and graft loss. #TXPforAll #Transplantation https://t.co/zpfSoQaWxH

[Transplantation @TransplantJrnl]

New meta-analysis: In > 7,000 kidney transplant recipients, SGLT2 inhibitors & GLP-1RAs were linked to better survival, cardiovascular & kidney outcomes, weight loss, lower HbA1c—without added safety risks! #TXPforAll #Transplantation https://t.co/ahMDhsZr8W

[Janewit Wongboonsin, MD, MS @janewitwong]

🧬Introducing our first-ever handbook of genetic nephrology, with free download until 8/2025

https://t.co/S4L4M1cFMh

@AndrewMallett8 and I saw a gap in foundational reading of genetic nephrology and decided to gather articles that clinician and learners can all enjoy

[Scholarship for PhD @ScholarshipfPhd]

PhD 😄

[BMA Medical Academics @BMA_Academics]

This @ukmedschools report https://t.co/NKsLnuXHln sets off further alarm bells on the state of Britain’s medical academic workforce. The Medical Schools Council data worryingly shows the entire pipeline is at threat - with both early career and senior roles declining. 1/

[Michael Corr @CorrMP]

Rectuitment ✔️

50 patients recruited at Belfast Trust for my study on why kidney transplants fail early in young people. Huge thanks to the Belfast City renal outpatient team & all the patients who agreed to take part.

Now off to Galway to analyse the samples. #KidneyResearch

[Neil Renic @NC_Renic]

Describing my research methodology

[Michael Corr @CorrMP]

From Belfast we again report on our efforts to expand access to peritoneal dialysis

We report our outcomes of PD catheter insertion and 1 year outcomes in individuals living with obesity

#dialysis #kidneyresearch
@stephenconeill @DamianFog

https://t.co/qS1xip9Dlc

[Kidney Research UK @Kidney_Research]

We know this statistic can be tough to see – especially if you’re waiting for a transplant or have recently received a new kidney. Please keep reading to understand why we’re sharing it 👇

We share these numbers not to scare, but to inform and support.

Education is key – a kidney transplant can be life-changing, but it’s not a cure. Sometimes, transplants can fail for reasons beyond anyone’s control, like the body rejecting the new kidney.

Awareness matters – many people don’t know the the impact a transplant can have on daily life and the lifetime of medication after. There are currently over 6,200 people waiting for a kidney transplant.

Here’s how we’re making a difference:

We’re funding ground-breaking research – including our latest award in honour of Professor Michael Nicholson, dedicated entirely to advancing kidney transplantation. Keep your eyes out for these projects on our social channels soon!

We’re sharing stories of hope – many of our incredible community members have lived with their transplanted kidneys for over 10 years. Their stories inspire, encourage, and remind us all that there is hope💜

[Kidney Research UK @Kidney_Research]

New government figures show people living with chronic kidney disease (CKD) are among the most severely affected patient groups, losing up to £14,721 in earnings over five years while facing a 9.4% fall in employment and a 16.3% rise in benefit claims following hospital diagnosis of their disease.

We need urgent action now to tackle the devastating impact of #CKD.

[Michael Corr @CorrMP]

Absolutely — and we also need clinical academics embedded in basic and exploratory science teams, where the next wave of discoveries for future clinical trials will begin.

[BMA Medical Academics @BMA_Academics]

Bringing more clinical trials to the UK population is to be welcomed, but raises the question of who’ll be designing, developing and overseeing these trials. Delivering such work requires more than Digital platforms & AI technologies. 1/

[Michael Corr @CorrMP]

A full-on but rewarding day recruiting some of Northern Ireland’s youngest kidney transplant recipients into research. Inspired by their willingness to help and take part in the study 💪

Also buzzing with my new @NIKRFcharity cap! 🧢
#KidneyResearch #TransplantResearch

[Jonathan Gibb @gibb_jonathan]

"There is a severe shortage of doctors working as clinical academics, which threatens the future of both research and medical education. We encourage government to address inequalities in total remuneration that disincentivise clinical academia as a career path" @BMA_Academics

[CKJ @CKJsocial]

Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients With Type 2 Diabetes and Advanced CKD:

Kidney And Cardiovascular Outcomes in a Real-World Setting

https://t.co/8FTuhF5A8h

[Michael Corr @CorrMP]

Problem when we chase headline figures, rather than try and deal with the systemic problems in the health service

[Michael Corr @CorrMP]

1.) Why not done just on clincial need and paid directly? Or used strategically to work on worst waiting lists
2.) Money out of the system, rather than trying to harness local state
3.) Only for those who can afford to pay upfront

Seems poorly thought through, unequal policy

[BBC News NI @BBCNewsNI]

People who have been on an NHS waiting list for more than two years will now be able to pay for procedures in the Republic of Ireland and claim money back. https://t.co/1WkUfHrERN